New antibody drug aims to rescue hearts in shock
Disease control
Recruiting now
This study tests a new drug called procizumab in people with cardiogenic shock, a condition where the heart suddenly can't pump enough blood to vital organs, often leading to death. The drug is designed to block a harmful protein (cDPP3) that rises during shock. About 130 adults …
Phase: PHASE1, PHASE2 • Sponsor: 4TEEN4 Pharmaceuticals GmbH • Aim: Disease control
Last updated May 15, 2026 11:56 UTC